Giuseppe Ciaramella, the leader of Moderna Therapeutics’ infectious diseases business, has jumped to a stealth-mode biotech startup, leaving a long list of clinical programs behind, according to STAT.Original Article
Moderna’s vaccines head steps down as multiple programs undergo phase 1: report
